ask="19.50"
ask_size="1200"
average_daily_volume="146977"
bid="N/A"
bid_size="N/A"
book_value="6.01"
change="+0.31"
change_from_200_day_moving_average="1.15"
change_from_50_day_moving_average="0.38"
change_from_52_week_high="-2.35"
change_From_52_week_low="5.08"
change_in_percent="+1.84%"
close="17.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.77"
ebitda="-62.58M"
eps_estimate_current_year="-3.37"
eps_estimate_next_quarter="-0.79"
eps_estimate_next_year="-1.70"
ex_dividend_date="N/A"
float_shares="11847000"
high="17.61"
high_52_weeks="19.50"
last_trade_date="3/9/2017"
last_trade_price="17.15"
last_trade_size="2966"
last_trade_time="4:00pm"
low="16.50"
low_52_weeks="12.07"
market_capitalization="381.06M"
moving_average_200_day="16.00"
moving_average_50_day="16.77"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.25"
open="16.85"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="+7.15%"
percent_change_from_50_day_moving_average="+2.26%"
percent_change_from_52_week_high="-12.05%"
percent_change_from_52_week_low="+42.09%"
previous_close="16.84"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.80"
price_per_sales="654.14"
revenue="572000.00"
shares_outstanding="22219000"
short_ratio="31.81"
stock_exchange="NGM"
symbol="ADMS"
volume="105483"
weeks_range_52="12.07 - 19.50"
